Stay updated on CANDOR Clinical Trial
Sign up to get notified when there's something new on the CANDOR Clinical Trial page.

Latest updates to the CANDOR Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNo significant additions or deletions were detected between the two screenshots. The page content remains consistent with the study details for NCT03158688.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedUpdated disease terminology to be current (Multiple myeloma) and bumped revision to v3.2.0; removed older term Plasma cell myeloma and older version v3.0.2; added a government-operating-status notice.SummaryDifference1%

- Check52 days agoChange DetectedNo substantive changes detected; only the removal of a 'Back to Top' link. The core content and other critical information remain unchanged.SummaryDifference0.1%

- Check59 days agoChange DetectedVersion metadata updated to v3.0.2, replacing the previous v3.0.0-post.1-g752effb-HEAD, and a Back to Top control was added for navigation. No substantive content changes (pricing, stock, proper nouns) were detected.SummaryDifference0.1%

- Check66 days agoChange DetectedThe web page has been updated to a new revision, indicating a potential enhancement or bug fix in the content or functionality.SummaryDifference0.0%

- Check73 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous facility names and locations across various countries, particularly in Europe and Asia, as well as the introduction of new medical terms related to plasma cell myeloma and associated treatments.SummaryDifference11%

Stay in the know with updates to CANDOR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CANDOR Clinical Trial page.